ISRCTN12061770
Active, not recruiting
未知
Reproductive function in teenage and young adult cancer patients in the UK
niversity of Edinburgh and NHS Lothian0 sites1,000 target enrollmentMarch 3, 2023
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Cancer and reproductive health
- Sponsor
- niversity of Edinburgh and NHS Lothian
- Enrollment
- 1000
- Status
- Active, not recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Willing and able to provide written informed consent (including by parent/guardian where appropriate).
- •2\. Aged 13\-25 years old
- •3\. First cancer diagnosis
- •4\. Requires cancer treatment (surgery, chemotherapy including targeted therapies, radiotherapy, bone marrow transplant).
Exclusion Criteria
- •1\. Inability to provide informed consent
- •2\. Does not require cancer treatment
- •3\. Where treatment is not given with the intention of cure or long\-term survival
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Effıcıency of Sexual and Reproductıve Health EducatıonReproductive HealthSexual HealthNCT05864430Marmara University165
Recruiting
Not Applicable
Fertility Preservation for Adolescent and Young Adult Women with cancer by means of Oocyte cryopreservatiocancer patient, autoimmune disease patientJPRN-UMIN000032034Hyogo College of Medicine College Hospital300
Recruiting
Not Applicable
Innovative Education Technology for Sexual and Reproductive Health for TeensCTRI/2018/02/012127Grand Challenges Canada
Completed
Phase 4
Evaluation of Growth, Sexual Maturation, and Prolactin-Related Adverse Events in the Pediatric Population Exposed to Atypical Antipsychotic DrugsNL-OMON34837Janssen-Cilag40
Active, not recruiting
Not Applicable
Evaluation of Growth, Sexual Maturation, and Prolactin-Related Adverse Events in the Pediatric Population Exposed to Atypical Antipsychotic Drugsong-term safety data in children and adolescents will be collected from a population of patients with a diagnosis of schizophrenia, bipolar mania, autistic disorder or conduct and other disruptive disorders undergoing routine standard of care treatment.MedDRA version: 12.1Level: LLTClassification code 10039626Term: SchizophreniaMedDRA version: 12.1Level: HLGTClassification code 10026753Term: Manic and bipolar mood disorders and disturbancesMedDRA version: 12.1Level: LLTClassification code 10003805Term: AutismEUCTR2009-012003-26-GRJanssen-Cilag International, NV350